Exclusive Online Content
The CDMO Market: Implications of Patheon's IPO
By: Patricia Van Arnum, DCAT Editorial Director, posted Tue, Jun 09, 2015 04:42 AM Patheon's announcement this week that it plans to file for an initial public…
SGS Life Science Services Opens New Lab; Broadens Biologics Capabilities
SGS Life Science Services, the leading analytical and bioanalytical contract solutions provider, today announced the planned opening of its new bio/pharmaceutical quality control laboratory at…
Glaucoma Treatment Market Value Will Grow Moderately to $3 Billion
The treatment market for glaucoma will rise in value from $2.4 billion in 2013 to approximately $3 billion by 2023 across the seven major markets…
Drug Abuse Triggers Regulations to Push the Development of Tamper-Resistant Opioid Formulations for Pain Management
The pain market is currently dominated by opioid analgesics, which have well-known side effects, such as addiction and constipation. However, a $10-billion market exists for…
Strategic Product Lifecycle Management Through Secondary Packaging
Developing and launching a new drug is often a burden on resources, time and money. Pharmaceutical and biotech companies can only afford the…
bluebird bio Announces Global Regulatory Strategy for Gene Therapy
bluebird bio, Inc., a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies, recently…
West Bolsters R&D Strategy With Global Site Expansions & Upgrades
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, today announced a multi-year investment as part of…
XenoTech Accepting Global Scientific Achievement Award Nominations for 2015
Lenexa, KS (May 18, 2015) – XenoTech, a division of Sekisui, is accepting nominations for the 2015 XenoTech Global Scientific Achievement Award. This award is…
Vcaps® Plus Capsules: A New HPMC Capsule for Optimum Formulation of Pharmaceutical Dosage Forms
abstract Hypromellose (HPMC) capsules were originally formulated with a secondary gelling agent. This agent can delay dissolution in some circumstances and lead to unwanted issues…
Recombinant & Prophylactic Treatments Boost Global Haemophilia Therapeutics Market
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are…
Alzheimer's Disease Treatment Market Value Will Exceed $13 Billion
The global market for Alzheimer’s Disease (AD) treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion…
Xcelience CEO & President Named Finalist in Entrepreneur of The Year 2015 Awards
Xcelience's Derek Hennecke has been named a finalist in the EY Entrepreneur Of The Year 2015 Florida Awards. Mr. Hennecke was selected from more than…
CMOCRO: Intuitive Platform Provides Quick Access to Global Database of Pharmaceutical Suppliers, Supports Partnering Decisions
By: Ashish Shukla, PhD CMOCRO is an intuitive platform designed to quickly access a global database of pharmaceutical suppliers, and aims to support…
Ease the Path To Biosimilars Approval
Biosimilars Market Exploding! Do You Know FDA Requirements? Successful 351(k) Biosimilar Applications When it comes to FDA approval for biosimilars, the devil is in the…
EMA Endorses Development of Generic Topicals
European regulators are looking to industry for suggestions on the best ways to get generic versions of topical drugs approved without having to conduct time-consuming…
Gx MultiShell Unites the Properties of Glass & Plastic
Every day, millions of people are treated with parenteral medications, such as precautionary vaccinations or injections and infusions for medical conditions. Gerresheimer supplies the pharmaceutical…
Teva's Potential $40-Billion Acquisition Could Transform Generics Space
Teva Pharmaceutical Industries’ recent $40.1-billion offer to purchase Netherlands-based Mylan, which is crucially contingent on Mylan not consummating its offer to acquire Irish firm Perrigo,…
Pipeline Advancements & Asset Acquisitions Fueled Mid-Cap Biotech Research & Development Spend in 2014
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a…
Q1 2015 Global Pharma, Medical & Biotech Trend Report
Mergermarket has released its Global Pharma, Medical & Biotech (PMB) trend report for the first quarter (Q1) of 2015. Take a look at the full…
New Jersey Pharmaceutical Association for Science & Technology Celebrates 60th Anniversary
The New Jersey Pharmaceutical Association for Science and Technology (NJPhAST) will be launching the celebration of its 60th anniversary at its September 17th meeting…
